CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-19 | Vounatsos Michel Chief Executive Officer | Grant or award | +10,594 | 63,666.19 | ||
| 2022-01-19 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Grant or award | +2,825 | 43,878 | ||
| 2021-12-08 | Kramer Robin Chief Accounting Officer | Grant or award · Restricted Stock Unit | +1,052 | 1,052 | ||
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Option exercise | +74 | $223.92 | $17K | 945.35 |
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Option exercise | +265 | $223.92 | $59K | 1,210.35 |
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −78 | $223.92 | $17K | 1,132.35 |
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −22 | $223.92 | $5K | 1,110.35 |
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −74 | 104 | ||
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Other disposition · Restricted Stock Unit | −104 | 0 | ||
| 2021-12-03 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −265 | 0 | ||
| 2021-12-02 | Izzar Rachid Head of Alzheimer's Disease | Option exercise | +372 | $228.52 | $85K | 1,271 |
| 2021-12-02 | Izzar Rachid Head of Alzheimer's Disease | Shares withheld for taxes | −165 | $228.52 | $38K | 1,106 |
| 2021-12-02 | Izzar Rachid Head of Alzheimer's Disease | Option exercise · Restricted Stock Unit | −372 | 1,342 | ||
| 2021-12-02 | Izzar Rachid Head of Alzheimer's Disease | Other disposition · Restricted Stock Unit | −484 | 858 | ||
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,681 | $338.24 | $907K | 2,681 |
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,141 | $338.24 | $386K | 1,540 |
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +3,324 | $338.24 | $1.1M | 4,864 |
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,441 | $338.24 | $487K | 3,423 |
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,681 | 5,364 | ||
| 2021-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,324 | 12,766 |
Page 34 of 45 · 886 trades